Non-contact antibody treatment apparatus
By using a non-contact antibody processing device, the connection between cells and antibodies is achieved through the charge effect at the end of the insulating layer. Furthermore, by using antisense oligonucleotide staining, the problem of cell-antibody binding in existing technologies is solved, enabling effective evaluation of biological characteristic expression.
Patent Information
- Application Number
- PCT/CN2026/076669
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-05-13
- Filing Date
- 2026-02-03
- Publication Date
- 2026-11-19
AI Technical Summary
Existing cell processing devices lack an effective mechanism for binding cells to antibodies, making it difficult for antibodies to bind to cells.
A non-contact antibody processing device is used, which uses the positively charged end of the insulating layer to attract and hold cells, and drives the antibody to connect with the cell through the electrode layer, and then stains the cell by binding antisense oligonucleotides.
It enables efficient cell-antibody binding and staining, and can obtain images of the biological characteristics expressed by cells or tissues, supporting subsequent evaluation and judgment.
Smart Images

Figure CN2026076669_19112026_PF_FP_ABST
Abstract
Description
Non-contact antibody processing equipment Technical Field
[0001] This application relates to a processing device, and more particularly to a non-contact antibody processing device. Background Technology
[0002] Existing cell processing devices mostly rely on conventional methods for attaching antibodies to cells, thus lacking any mechanism to facilitate antibody binding to the cells. Therefore, the applicant believes these deficiencies can be improved and proposes this application with a rationally designed and effective solution to overcome them. Summary of the Invention
[0003] This application provides a non-contact antibody processing device that can effectively improve upon the shortcomings that may arise from existing cell processing devices.
[0004] This application discloses a non-contact antibody processing device, comprising: a sample supply device for providing a liquid sample having multiple cells and multiple antibodies that do not contact the multiple cells; wherein each cell carries a negative charge and each antibody has a positive oligonucleotide; a capture device for containing the liquid sample from the sample supply device, and the capture device comprising: a field emission structure including a first substrate, a first electrode layer formed on the first substrate, and multiple pillars; wherein the multiple pillars are located inside the field emission structure and are spaced apart from each other; a mating structure spaced apart from the field emission structure along a thickness direction; wherein the mating structure includes The device includes a second substrate and a second electrode layer formed on the second substrate; a power supply device electrically coupled to the first electrode layer and the second electrode layer; wherein the power supply device can drive a capture device to give the free ends of a plurality of columns a positive charge for attracting and holding a plurality of cells and attracting a plurality of antibodies to connect to the plurality of cells; and a staining device connected to the capture device; wherein when a plurality of cells are held in a plurality of columns and connected to a plurality of antibodies, the staining device can be used to input a plurality of first antisense oligonucleotides so that the sense oligonucleotide of at least one antibody connected to each cell is connected to the corresponding first antisense oligonucleotide, thereby realizing a first staining operation.
[0005] Optionally, the non-contact antibody processing device further includes a temperature control device electrically coupled to the capture device; wherein the capture device is maintained by the temperature control device at a first preset temperature suitable for the connection of the sense oligonucleotide and the corresponding first antisense oligonucleotide.
[0006] Optionally, after the first staining operation is completed, the capture device can be adjusted by a temperature control device to a second preset temperature, which is higher than the first preset temperature, suitable for separating the sense oligonucleotide and the corresponding first antisense oligonucleotide from each other.
[0007] Optionally, the first preset temperature is between 34°C and 39°C, and the second preset temperature is between 39°C and 44°C.
[0008] Optionally, after the first staining operation is completed and the positive oligonucleotide and the corresponding first antisense oligonucleotide are separated from each other, the staining device can be used to introduce multiple second antisense oligonucleotides so that the positive oligonucleotide of at least one antibody linked to each cell is linked to the corresponding second antisense oligonucleotide, thereby achieving a second staining operation.
[0009] Optionally, each first antisense oligonucleotide is linked to a first dye via a linker, and each second antisense oligonucleotide is linked to a second dye via a linker, wherein the color of the first dye is different from the color of the second dye.
[0010] Optionally, the field emission structure includes a semiconductor layer adjacent to a plurality of pillars, and the first electrode layer and the semiconductor layer are respectively formed on opposite sides of the first substrate.
[0011] This application also discloses a non-contact antibody processing device, comprising: a sample supply device for providing a liquid sample having multiple cells and multiple antibodies that do not contact the multiple cells; wherein each cell carries a negative charge; a capture device for containing the liquid sample from the sample supply device, and the capture device comprising: a field emission structure including a first substrate, a first electrode layer formed on the first substrate, and an insulating layer; wherein the insulating layer is located inside the field emission structure; a mating structure spaced apart from the field emission structure along a thickness direction; wherein the mating structure includes a second substrate and a second electrode layer formed on the second substrate; a power supply device electrically coupled to the first electrode layer and the second electrode layer; wherein the power supply device can drive the capture device to make the ends of the insulating layer carry a positive charge, for attracting and holding multiple cells, and attracting multiple antibodies to connect to the multiple cells.
[0012] Optionally, the insulating layer includes a plurality of pillars spaced apart from each other, and the power supply can drive the capture device to give the free ends of the plurality of pillars of the insulating layer a positive charge.
[0013] Optionally, the field emission structure includes a semiconductor layer adjacent to a plurality of pillars, and the first electrode layer and the semiconductor layer are respectively formed on opposite sides of the first substrate.
[0014] This application also discloses a non-contact antibody processing device, comprising: a sample supply device for providing a liquid sample having a plurality of antibodies; wherein each antibody has a negatively charged positive oligonucleotide; a capture device for containing the liquid sample from the sample supply device, and the capture device comprising: a field emission structure including a first substrate, a first electrode layer formed on the first substrate, and a plurality of pillars; wherein the plurality of pillars are located inside the field emission structure and spaced apart from each other; a mating structure spaced apart from the field emission structure along a thickness direction; wherein the mating structure includes a second substrate and a second electrode layer formed on the second substrate; a power supply device electrically coupled to the first electrode layer and the second electrode layer; wherein the capture device allows a tissue to be disposed therein and on the second substrate, and the power supply device can drive the capture device to make the free ends of the plurality of pillars negatively charged, so as to repel and drive the plurality of antibodies to move and connect to the tissue.
[0015] Optionally, each antibody has a positive oligonucleotide; the non-contact antibody processing device further includes a staining device connected to the capture device; wherein, when the tissue is placed on the second substrate and connected to multiple antibodies, the staining device can be used to input multiple first antisense oligonucleotides, so that the positive oligonucleotide of at least one antibody connected to the tissue is linked to the corresponding first antisense oligonucleotide, thereby achieving a first staining operation.
[0016] Optionally, after the first staining operation is completed, the power supply can drive the capture device to give the free ends of the multiple columns a positive charge, so as to attract and separate the corresponding first antisense oligonucleotide from the sense oligonucleotide of at least one antibody in the connecting tissue.
[0017] Optionally, after the first staining operation is completed and the positive oligonucleotide and the corresponding first antisense oligonucleotide are separated from each other, the staining device can be used to introduce multiple second antisense oligonucleotides so that the positive oligonucleotide of at least one antibody linked to the tissue is linked to the corresponding second antisense oligonucleotide, thereby achieving a second staining operation.
[0018] Optionally, each first antisense oligonucleotide is linked to a first dye via a linker, and each second antisense oligonucleotide is linked to a second dye via a linker, wherein the color of the first dye is different from the color of the second dye.
[0019] In summary, the non-contact antibody processing device disclosed in this application can, through the configuration of the capture device, effectively achieve the fixation of multiple cells and their connection with multiple antibodies by having the ends of the insulating layer (e.g., the free ends of multiple columns) carry a positive charge, or effectively achieve the connection of the tissue and multiple antibodies by having the ends of the insulating layer (e.g., the free ends of multiple columns) carry a negative charge.
[0020] Furthermore, the non-contact antibody processing device disclosed in the embodiments of this application can obtain a staining image corresponding to the biological characteristics expressed by each cell or tissue through the first staining operation of each cell, thereby facilitating various subsequent evaluations and judgments. Attached Figure Description
[0021] Figure 1 is a three-dimensional schematic diagram of the non-contact antibody processing device according to Embodiment 1 of this application.
[0022] Figure 2 is a cross-sectional view along section line II-II of Figure 1.
[0023] Figure 3 is a cross-sectional view of the subsequent operation of Figure 2.
[0024] Figure 4 is a cross-sectional view of the subsequent operation of Figure 3.
[0025] Figure 5 is a cross-sectional view of the subsequent operation of Figure 4.
[0026] Figure 6 is a cross-sectional view of the subsequent operation of Figure 5.
[0027] Figure 7 is a cross-sectional view of the subsequent operation of Figure 6.
[0028] Figure 8 is a cross-sectional view of the subsequent operation of Figure 7.
[0029] Figure 9 is a cross-sectional schematic diagram of the non-contact antibody processing device according to Embodiment 2 of this application.
[0030] Figure 10 is a cross-sectional view of the subsequent operation of Figure 9.
[0031] Figure 11 is a cross-sectional view of the subsequent operation of Figure 10.
[0032] Figure 12 is a cross-sectional view of the subsequent operation of Figure 11.
[0033] Figure 13 is a cross-sectional view of the subsequent operation of Figure 12. Detailed Implementation
[0034] The following specific embodiments illustrate the implementation of the "non-contact antibody processing device" disclosed in this application. Those skilled in the art can understand the advantages and effects of this application from the content disclosed in this specification. This application can be implemented or applied through other different specific embodiments, and the details in this specification can also be modified and changed based on different viewpoints and applications without departing from the concept of this application. Furthermore, the accompanying drawings in this application are for simple illustrative purposes only and are not depictions of actual dimensions, as stated in advance. The following embodiments will further describe the relevant technical content of this application in detail, but the disclosed content is not intended to limit the scope of protection of this application.
[0035] It should be understood that while terms such as "first," "second," and "third" may be used in this document to describe various components or features, these components or features should not be limited by these terms. These terms are primarily used to distinguish one component from another, or one feature from another. Furthermore, the term "or" as used in this document should, as appropriate, include any combination of one or more related listed items.
[0036] [Example 1]
[0037] Please refer to Figures 1 to 8, which illustrate Embodiment 1 of this application. As shown in Figure 1, this embodiment discloses a non-contact antibody processing device 1000, which includes a capture device 100, a sample supply device 200 connected to the capture device 100, a staining device 300 connected to the capture device 100, a power supply device 400 (e.g., an AC power device) electrically coupled to the capture device 100, and a temperature control device 500 electrically coupled to the capture device 100. However, this application is not limited to this. For example, in other embodiments not shown in this application, the staining device 300 and / or the temperature control device 500 may be omitted or replaced with other mechanisms according to actual needs.
[0038] As shown in Figures 2 to 5, the sample supply device 200 provides a liquid sample S having a plurality of cells P and a plurality of antibodies A not touching the plurality of cells P. Each cell P carries a negative charge, and each antibody A has a sense oligonucleotide A1, which may also carry a negative charge. However, for ease of explanation and understanding of this embodiment, only a partial structure of the non-contact antibody processing device 1000 is shown in the figures, thus the corresponding liquid sample S contains only one cell P and one antibody A.
[0039] It should be noted that, in this embodiment, the sample supply device 200 first inputs the liquid sample S containing multiple cells P but not multiple antibodies A, and then inputs the liquid sample S containing multiple antibodies A at an appropriate time; or, in other embodiments not shown in this application, the sample supply device 200 may also input the liquid sample S containing multiple cells P and multiple antibodies A according to actual needs.
[0040] The liquid sample S can be a bodily fluid sample from an animal (e.g., blood, lymph, saliva, or urine), and the cells P can be a specific type of cell or cell cluster, such as circulating tumor cells (CTCs), fetal nucleated red blood cells (FNRBCs), or bacteria, but this application is not limited to the above. For example, in other embodiments not shown in this application, the liquid sample S can also be a liquid sample from a plant.
[0041] The capture device 100 is a rectangular structure at the chip-scale, and is used to contain the liquid sample S from the sample supply device 200. The capture device 100 includes a field emission structure 1, a mating structure 2 spaced apart from the field emission structure 1 along a thickness direction H, and an adhesive layer 3 joining the periphery of the field emission structure 1 and the periphery of the mating structure 2 (as shown in Figure 1). The field emission structure 1 is located below the mating structure 2, and at least one of the field emission structure 1 and the mating structure 2 is transparent. In this embodiment, the field emission structure 1 and the mating structure 2 are two plate-like structures arranged parallel to each other, and the distance between them is greater than the size of any one of the cells P, but this application is not limited to the above.
[0042] The field emission structure 1 includes a first substrate 11, a first electrode layer 12 formed on the first substrate 11, a semiconductor layer 13 formed on the first substrate 11, and an insulating layer 14 formed on the semiconductor layer 13, but this application is not limited thereto. For example, in other embodiments not shown in this application, the semiconductor layer 13 of the field emission structure 1 may be omitted or replaced with other structures according to actual needs.
[0043] In this embodiment, the first electrode layer 12 is formed on the bottom side of the first substrate 11, and the semiconductor layer 13 is formed on the top side of the first substrate 11 (that is, the first electrode layer 12 and the semiconductor layer 13 are formed on opposite sides of the first substrate 11). The insulating layer 14 formed on the semiconductor layer 13 is located inside the field emission structure 1. Further, the insulating layer 14 includes a plurality of pillars 141 located inside the field emission structure 1 and spaced apart from each other (e.g., the plurality of pillars 141 are adjacent to the semiconductor layer 13). The semiconductor layer 13 has a plurality of transistors 131 arranged in a matrix. The semiconductor layer 13 can adopt an NPN transistor architecture, a PNP transistor architecture, an NP diode architecture, or a PN diode architecture according to actual needs, but this application is not limited to this. In other words, according to actual needs, the semiconductor layer 13 (e.g., the plurality of transistors 131) provided in this embodiment can be driven to provide a corona discharge function for the cell P.
[0044] The mating structure 2 includes a second substrate 21 and a second electrode layer 22 formed on the second substrate 21, with the second electrode layer 22 facing the field emission structure 1 (e.g., the insulating layer 14). In this embodiment, the power supply device 400 is electrically coupled to the first electrode layer 12 of the field emission structure 1 and the second electrode layer 22 of the mating structure 2; thereby, the power supply device 400 can drive the capture device 100 to make the ends of the insulating layer 14 (e.g., the free ends 1411 of the plurality of pillars 141) carry a positive charge to attract and hold the plurality of cells P and attract the plurality of antibodies A to connect to the plurality of cells P.
[0045] Furthermore, in this embodiment, the sample supply device 200 first inputs the liquid sample S containing multiple cells P but not multiple antibodies A, and after the free ends 1411 of the multiple columns 141 are positively charged to attract and hold the multiple cells P, the sample supply device 200 then inputs the liquid sample S containing multiple antibodies A, so that the multiple antibodies A are attracted to the multiple cells P by the free ends 1411 of the multiple columns 141 with positive charges. However, this application is not limited to this.
[0046] As described above, in this embodiment, the non-contact antibody processing device 1000 can, through the configuration of the capture device 100, effectively achieve the fixation of multiple cells P and their connection with multiple antibodies A by having the ends of the insulating layer 14 (e.g., the free ends 1411 of multiple pillars 141) carry a positive charge.
[0047] As shown in Figures 5 and 6, when multiple cells P are held in multiple columns 141 (e.g., the free ends 1411) and linked to multiple antibodies A, the staining device 300 can be used to input multiple first antisense oligonucleotides O1, so that the sense oligonucleotide A1 of at least one antibody A linked to each cell P is linked to the corresponding first antisense oligonucleotide O1, thereby achieving a first staining operation.
[0048] Therefore, the non-contact antibody processing device 1000 can obtain a staining image corresponding to the biological characterization expression of each cell P through the first staining operation, thereby facilitating subsequent evaluation and judgment. Further, each of the first antisense oligonucleotides O1 is connected to a first dye O12 via a linker O11, thereby achieving the first staining operation through the color of the first dye O12, but this application is not limited thereto. For example, in other embodiments not shown in this application, the first dye O12 can also be implemented according to actual needs (e.g., the first dye O12 can be magnetic beads or colored plastic microparticles).
[0049] It should be further noted that, as shown in Figure 6, the capture device 100 can be maintained at a first preset temperature suitable for the connection of the positive oligonucleotide A1 and the corresponding first antisense oligonucleotide O1 by the temperature control device 500. Furthermore, as shown in Figure 7, after the first staining operation is completed, the capture device 100 can be adjusted by the temperature control device 500 to a second preset temperature suitable for the separation of the positive oligonucleotide A1 and the corresponding first antisense oligonucleotide O1, which is higher than the first preset temperature. In this embodiment, the first preset temperature is generally higher than 35°C (e.g., between 34°C and 39°C), and the second preset temperature is generally higher than 40°C (e.g., between 39°C and 44°C), but is not limited thereto.
[0050] Furthermore, as shown in Figures 7 and 8, after the first staining operation is completed and the positive oligonucleotide A1 and the corresponding first antisense oligonucleotide O1 are separated from each other, the staining device 300 can be used to input a plurality of second antisense oligonucleotides O2, so that the positive oligonucleotide A1 of at least one antibody A linked to each cell P is linked to the corresponding second antisense oligonucleotide O2, thereby realizing a second staining operation. Each second antisense oligonucleotide O2 is connected to a second dye O22 via a linker O21, and the color of the first dye O12 is different from the color of the second dye O22. The second dye O22 can also be implemented according to actual needs (e.g., the second dye O22 can be magnetic beads or colored plastic microparticles).
[0051] Therefore, the multiple cells P held by the capture device 100 can undergo N staining operations through the above-described process to obtain multiple staining images corresponding to the expression of N biological characteristics. In this embodiment, N is a positive integer between 2 and 50, and N is preferably between 4 and 28, but this application is not limited thereto. That is, each staining operation of the cell P can correspond to the expression of one biological characteristic, thereby facilitating various subsequent evaluations and judgments of the cell P. In addition, the non-contact antibody processing device 1000 can further superimpose the multiple staining images to obtain the biological characteristics of the cell P.
[0052] [Example 2]
[0053] Please refer to Figures 9 to 13, which illustrate Embodiment Two of this application. Since this embodiment is similar to Embodiment One described above, the similarities between the two embodiments will not be repeated. The main differences between this embodiment and Embodiment One are explained below:
[0054] In this embodiment, the non-contact antibody processing device 1000 includes a capture device 100, a sample supply device 200 connected to the capture device 100, a staining device 300 connected to the capture device 100, a power supply device 400 (e.g., an AC power device) electrically coupled to the capture device 100, and a temperature control device 500 electrically coupled to the capture device 100. However, this application is not limited to this. For example, in other embodiments not shown in this application, the staining device 300 and / or the temperature control device 500 may be omitted or replaced with other mechanisms according to actual needs.
[0055] It should be noted that the structure and connection relationship of the capture device 100, the specimen supply device 200, the staining device 300, the power supply device 400, and the temperature control device 500 in this embodiment are generally the same as those described in Embodiment 1, and will not be repeated here.
[0056] As shown in Figure 9, the main difference between the sample supply device 200 in this embodiment and that in Embodiment 1 is that the liquid sample S provided by the sample supply device 200 in this embodiment does not include multiple cells. Furthermore, in this embodiment, the sample supply device 200 is used to provide a liquid sample S containing multiple antibodies A, and each antibody A has a negatively charged positive oligonucleotide A1.
[0057] As shown in Figures 9 and 10, the main difference between the capture device 100 in this embodiment and that in Embodiment 1 is that the field emission structure 1 is located above the mating structure 2, and the second substrate 21 (e.g., a glass substrate) of the mating structure 2 is located inside and faces the insulating layer 14. Thus, the capture device 100 allows a tissue T to be disposed therein and on the second substrate 21, and the power supply device 400 can drive the capture device 100 so that the ends of the insulating layer 14 (e.g., the free ends 1411 of the plurality of pillars 141) carry a negative charge, thereby repelling and driving the plurality of antibodies A to move and connect to the tissue T (e.g., multiple cells of the tissue T). The tissue T can be obtained from animals or plants according to actual needs, and this application does not impose any limitations.
[0058] As described above, in this embodiment, the non-contact antibody processing device 1000 can, through the configuration of the capture device 100, facilitate the connection of the tissue T and the multiple antibodies A by having the ends of the insulating layer 14 (e.g., the free ends 1411 of the plurality of pillars 141) carry a negative charge.
[0059] As shown in Figures 10 and 11, when the tissue T is disposed on the second substrate 21 and connected to a plurality of antibodies A, the staining device 300 can be used to input a plurality of first antisense oligonucleotides O1, so that the sense oligonucleotide A1 of at least one antibody A connected to the tissue T can be connected to the corresponding first antisense oligonucleotide O1, thereby effectively realizing a first staining operation.
[0060] Therefore, in this embodiment, the non-contact antibody processing device 1000 can obtain a staining image corresponding to the biological characteristics expressed in the tissue T through the first staining operation, thereby facilitating subsequent evaluation and judgment. Further, each of the first antisense oligonucleotides O1 is connected to a first dye O12 via a linker O11, thereby achieving the first staining operation through the color of the first dye O12, but this application is not limited thereto. For example, in other embodiments not shown in this application, the first dye O12 can also be implemented in other ways according to actual needs (e.g., the first dye O12 can be replaced by colored plastic microparticles).
[0061] It should be further noted that, as shown in Figure 11, the capture device 100 can be maintained at a first preset temperature suitable for the connection of the positive oligonucleotide A1 and the corresponding first antisense oligonucleotide O1 by the temperature control device 500. Furthermore, as shown in Figure 12, after the first staining operation is completed, the capture device 100 can be adjusted by the temperature control device 500 to a second preset temperature suitable for the separation of the positive oligonucleotide A1 and the corresponding first antisense oligonucleotide O1, which is higher than the first preset temperature. In this embodiment, the first preset temperature is generally higher than 35°C (e.g., between 34°C and 39°C), and the second preset temperature is generally higher than 40°C (e.g., between 39°C and 44°C), but is not limited thereto.
[0062] Furthermore, as shown in FIG12, after the first staining operation is completed, the power supply device 400 can drive the capture device 100 to make the free ends 1411 of the plurality of columns 141 positively charged, so as to attract and separate the corresponding first antisense oligonucleotide O1 from the sense oligonucleotide A1 of at least one antibody A connected to the tissue T.
[0063] Furthermore, as shown in Figures 12 and 13, after the first staining operation is completed and the positive oligonucleotide A1 and the corresponding first antisense oligonucleotide O1 are separated from each other, the staining device 300 can be used to input a plurality of second antisense oligonucleotides O2, so that the positive oligonucleotide A1 of at least one antibody A linked to the tissue T is linked to the corresponding second antisense oligonucleotide O2, thereby realizing a second staining operation. Each second antisense oligonucleotide O2 is connected to a second dye O22 via a linker O21, and the color of the first dye O12 is different from the color of the second dye O22.
[0064] Therefore, the tissue T within the capture device 100 can undergo N staining operations through the above-described process to obtain multiple staining images corresponding to the expression of N biological characteristics. In this embodiment, N is a positive integer between 2 and 50, and N is preferably between 4 and 28, but this application is not limited thereto. That is, each staining operation of the tissue T can correspond to one of the expressed biological characteristics, thereby facilitating various subsequent evaluations and judgments of the tissue T. Furthermore, the non-contact antibody processing device 1000 can further overlay multiple staining images to obtain the biological characteristics of the tissue T.
[0065] [Technical Effects of the Embodiments in this Application]
[0066] In summary, the non-contact antibody processing device disclosed in this application can, through the configuration of the capture device, effectively achieve the fixation of multiple cells and their connection with multiple antibodies by having the ends of the insulating layer (e.g., the free ends of multiple columns) carry a positive charge, or effectively achieve the connection of the tissue and multiple antibodies by having the ends of the insulating layer (e.g., the free ends of multiple columns) carry a negative charge.
[0067] Furthermore, the non-contact antibody processing device disclosed in the embodiments of this application can obtain a staining image corresponding to the biological characteristics expressed by each cell or tissue through the first staining operation of each cell, thereby facilitating various subsequent evaluations and judgments.
[0068] Furthermore, the non-contact antibody processing device disclosed in this application can obtain multiple staining images corresponding to the expression of N biological characteristics through N staining operations. That is, each staining operation of each cell or tissue can correspond to the expression of one biological characteristic, thereby facilitating various subsequent evaluations and judgments of the tissue.
[0069] The embodiments and / or implementation methods described above are merely preferred embodiments and / or implementation methods for implementing the technology of this application, and are not intended to limit the implementation methods of the technology of this application in any way. Any person skilled in the art may make some modifications or alterations to other equivalent embodiments without departing from the scope of the technical means disclosed in this application, but these should still be regarded as the technology or embodiments that are substantially the same as those of this application.
Claims
1. A non-contact antibody processing apparatus characterized by, The non-contact antibody processing equipment includes: A sample supply device for providing a liquid sample having a plurality of cells and a plurality of antibodies that do not contact the plurality of cells; wherein each of the cells is negatively charged and each of the antibodies has a positive oligonucleotide; A capture device for containing the liquid sample from the sample supply device, and the capture device includes: A field emission structure includes a first substrate, a first electrode layer formed on the first substrate, and a plurality of pillars; wherein the plurality of pillars are located inside the field emission structure and are spaced apart from each other; and A mating structure is spaced apart from the field emission structure along a thickness direction; wherein the mating structure includes a second substrate and a second electrode layer formed on the second substrate; A power supply device electrically coupled to the first electrode layer and the second electrode layer; wherein the power supply device is capable of driving the capture device to give positive charges to the free ends of the plurality of columns for attracting and holding the plurality of cells and attracting the plurality of antibodies to connect to the plurality of cells; and A staining device connected to the capture device; When multiple cells are held in multiple columns and linked to multiple antibodies, the staining device can be used to introduce multiple first antisense oligonucleotides so that the sense oligonucleotide of at least one antibody linked to each cell is linked to the corresponding first antisense oligonucleotide, thereby achieving a first staining operation.
2. The non-contact antibody treatment apparatus according to claim 1, wherein The non-contact antibody processing device further includes a temperature control device electrically coupled to the capture device; wherein the capture device can be maintained by the temperature control device at a first preset temperature suitable for the connection of the sense oligonucleotide and the corresponding first antisense oligonucleotide.
3. The non-contact antibody treatment apparatus according to claim 2, characterized by After the first staining operation is completed, the capture device can be adjusted by the temperature control device to a second preset temperature, which is higher than the first preset temperature, suitable for separating the sense oligonucleotide and the corresponding first antisense oligonucleotide from each other.
4. The non-contact antibody treatment apparatus according to claim 3, wherein The first preset temperature is between 34°C and 39°C, and the second preset temperature is between 39°C and 44°C.
5. The non-contact antibody treatment apparatus according to claim 3, wherein After the first staining operation is completed and the positive oligonucleotide and the corresponding first antisense oligonucleotide are separated from each other, the staining device can be used to input a plurality of second antisense oligonucleotides so that the positive oligonucleotide of at least one antibody linked to each cell is linked to the corresponding second antisense oligonucleotide, thereby achieving a second staining operation.
6. The non-contact antibody treatment apparatus according to claim 5, wherein Each of the first antisense oligonucleotides is linked to a first dye via a linker, and each of the second antisense oligonucleotides is linked to a second dye via a linker, wherein the color of the first dye is different from the color of the second dye.
7. The non-contact antibody treatment apparatus according to claim 1, wherein The field emission structure includes a semiconductor layer adjacent to the plurality of pillars, and the first electrode layer and the semiconductor layer are respectively formed on opposite sides of the first substrate.
8. A non-contact antibody processing apparatus characterized by, The non-contact antibody processing equipment includes: A sample supply device for providing a liquid sample having a plurality of cells and a plurality of antibodies that do not contact the plurality of cells; wherein each of the cells carries a negative charge; A capture device for containing the liquid sample from the sample supply device, and the capture device includes: A field emission structure includes a first substrate, a first electrode layer formed on the first substrate, and an insulating layer; wherein the insulating layer is located inside the field emission structure; and A mating structure, spaced apart from the field emission structure along a thickness direction; wherein the mating structure includes a second substrate and a second electrode layer formed on the second substrate; and A power supply device electrically coupled to the first electrode layer and the second electrode layer; The power supply device can drive the capture device to give the end of the insulating layer a positive charge, so as to attract and hold multiple cells and attract multiple antibodies to connect to multiple cells.
9. The non-contact antibody treatment apparatus according to claim 8, wherein The insulating layer includes a plurality of pillars spaced apart from each other, and the power supply device is capable of driving the capture device to cause the free ends of the plurality of pillars of the insulating layer to carry the positive charge.
10. The non-contact antibody treatment apparatus according to claim 9, wherein The field emission structure includes a semiconductor layer adjacent to the plurality of pillars, and the first electrode layer and the semiconductor layer are respectively formed on opposite sides of the first substrate.
11. A non-contact antibody processing apparatus characterized by comprising: The non-contact antibody processing equipment includes: A sample supply device for providing a liquid sample having a plurality of antibodies; wherein each of the antibodies has a negatively charged positive oligonucleotide; A capture device for containing the liquid sample from the sample supply device, and the capture device includes: A field emission structure includes a first substrate, a first electrode layer formed on the first substrate, and a plurality of pillars; wherein the plurality of pillars are located inside the field emission structure and are spaced apart from each other; and A mating structure, spaced apart from the field emission structure along a thickness direction; wherein the mating structure includes a second substrate and a second electrode layer formed on the second substrate; and A power supply device electrically coupled to the first electrode layer and the second electrode layer; The capture device allows a tissue to be disposed therein and located on the second substrate, and the power supply device drives the capture device to give the free ends of the plurality of columns a negative charge, so as to repel and drive the plurality of antibodies to move and connect to the tissue.
12. The non-contact antibody treatment apparatus according to claim 11, wherein Each of the antibodies has a positive oligonucleotide; the non-contact antibody processing device further includes a staining device connected to the capture device; wherein, when the tissue is disposed on the second substrate and connected to a plurality of the antibodies, the staining device can be used to input a plurality of first antisense oligonucleotides, so that the positive oligonucleotide of at least one of the antibodies connected to the tissue is linked to the corresponding first antisense oligonucleotide, thereby achieving a first staining operation.
13. The non-contact antibody treatment apparatus according to claim 12, wherein When the first staining operation is completed, the power device drives the capturing device to make the free ends of the plurality of columns carry positive charges to attract and separate the first antisense oligonucleotides from the sense oligonucleotides connected to the antibodies of the tissue.
14. The non-contact antibody treatment apparatus according to claim 13, wherein When the first staining operation is completed and the sense oligonucleotides are separated from the first antisense oligonucleotides, the staining device can input second antisense oligonucleotides to connect the sense oligonucleotides connected to the antibodies of the tissue to the second antisense oligonucleotides, thereby realizing a second staining operation.
15. The non-contact antibody treatment apparatus according to claim 14, wherein Each of the first antisense oligonucleotides is connected to a first dye through a linker, each of the second antisense oligonucleotides is connected to a second dye through a linker, and the color of the first dye is different from the color of the second dye.
